Barclays Cuts Charles River Laboratories International (NYSE:CRL) Price Target to $166.00
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price target cut by equities research analysts at Barclays from $205.00 to $166.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price target indicates a potential upside of 0.61% from […]
Charles River Laboratories International (NYSE:CRL – Get Free Report) had its price target cut by equities research analysts at Barclays from $205.00 to $166.00 in a report issued on Tuesday,Benzinga reports. The brokerage currently has an “equal weight” rating on the medical research company’s stock. Barclays‘s price target indicates a potential upside of 0.61% from […]
